Literature DB >> 17553924

Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides.

Martin Göttle1, Stefan Dove, Phillip Steindel, Yuequan Shen, Wei-Jen Tang, Jens Geduhn, Burkhard König, Roland Seifert.   

Abstract

The calmodulin (CaM)-dependent adenylyl cyclase (AC) toxin from Bordetella pertussis (CyaA) substantially contributes to the pathogenesis of whooping cough. Thus, potent and selective CyaA inhibitors may be valuable drugs for prophylaxis of this disease. We examined the interactions of fluorescent 2',3'-N-methylanthraniloyl (MANT)-, anthraniloyl- and trinitrophenyl (TNP)-substituted nucleotides with CyaA. Compared with mammalian AC isoforms and Bacillus anthracis AC toxin edema factor, nucleotides inhibited catalysis by CyaA less potently. Introduction of the MANT substituent resulted in 5- to 170-fold increased potency of nucleotides. K(i) values of 3'MANT-2'd-ATP and 2'MANT-3'd-ATP in the AC activity assay using Mn(2+) were 220 and 340 nM, respectively. Natural nucleoside 5'-triphosphates, guanine-, hypoxanthine- and pyrimidine-MANT- and TNP nucleotides and di-MANT nucleotides inhibited CyaA, too. MANT nucleotide binding to CyaA generated fluorescence resonance energy transfer (FRET) from tryptophans Trp69 and Trp242 and multiple tyrosine residues, yielding K(d) values of 300 nM for 3'MANT-2'd-ATP and 400 nM for 2'MANT-3'd-ATP. Fluorescence experiments and docking approaches indicate that the MANT- and TNP groups interact with Phe306. Increases of FRET and direct fluorescence with MANT nucleotides were strictly CaM-dependent, whereas TNP nucleotide fluorescence upon binding to CyaA increased in the absence of CaM and was actually reduced by CaM. In contrast to low-affinity MANT nucleotides, even low-affinity TNP nucleotides generated strong fluorescence increases upon binding to CyaA. We conclude that the catalytic site of CyaA possesses substantial conformational freedom to accommodate structurally diverse ligands and that certain ligands bind to CyaA even in the absence of CaM, facilitating future inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553924     DOI: 10.1124/mol.107.034413

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  20 in total

1.  Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I.

Authors:  Dominik Schuler; Carolin Lübker; Gerald H Lushington; Wei-Jen Tang; Yuequan Shen; Mark Richter; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2012-01-13       Impact factor: 5.858

2.  Inhibition of the adenylyl cyclase toxin, edema factor, from Bacillus anthracis by a series of 18 mono- and bis-(M)ANT-substituted nucleoside 5'-triphosphates.

Authors:  Hesham Taha; Stefan Dove; Jens Geduhn; Burkhard König; Yuequan Shen; Wei-Jen Tang; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

3.  Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA.

Authors:  Martin Göttle; Stefan Dove; Frieder Kees; Jens Schlossmann; Jens Geduhn; Burkhard König; Yuequan Shen; Wei-Jen Tang; Volkhard Kaever; Roland Seifert
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

4.  Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.

Authors:  Srividya Suryanarayana; Martin Göttle; Melanie Hübner; Andreas Gille; Tung-Chung Mou; Stephen R Sprang; Mark Richter; Roland Seifert
Journal:  J Pharmacol Exp Ther       Date:  2009-06-03       Impact factor: 4.030

5.  Distinct interactions of 2'- and 3'-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor.

Authors:  Srividya Suryanarayana; Jenna L Wang; Mark Richter; Yuequan Shen; Wei-Jen Tang; Gerald H Lushington; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2009-08-01       Impact factor: 5.858

6.  Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides.

Authors:  Hesham M Taha; Jennifer Schmidt; Martin Göttle; Srividya Suryanarayana; Yuequan Shen; Wei-Jen Tang; Andreas Gille; Jens Geduhn; Burkhard König; Stefan Dove; Roland Seifert
Journal:  Mol Pharmacol       Date:  2008-12-04       Impact factor: 4.436

7.  Structure-activity relationships for the interactions of 2'- and 3'-(O)-(N-methyl)anthraniloyl-substituted purine and pyrimidine nucleotides with mammalian adenylyl cyclases.

Authors:  Cibele Pinto; Gerald H Lushington; Mark Richter; Andreas Gille; Jens Geduhn; Burkhard König; Tung-Chung Mou; Stephen R Sprang; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2011-05-18       Impact factor: 5.858

8.  An Experimental Tool to Estimate the Probability of a Nucleotide Presence in the Crystal Structures of the Nucleotide-Protein Complexes.

Authors:  Maria Nemchinova; Vitaly Balobanov; Ekaterina Nikonova; Natalia Lekontseva; Alisa Mikhaylina; Svetlana Tishchenko; Alexey Nikulin
Journal:  Protein J       Date:  2017-06       Impact factor: 2.371

9.  Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases.

Authors:  Petra Břehová; Markéta Šmídková; Jan Skácel; Martin Dračínský; Helena Mertlíková-Kaiserová; Monica P Soto Velasquez; Val J Watts; Zlatko Janeba
Journal:  ChemMedChem       Date:  2016-10-24       Impact factor: 3.466

10.  Novel inhibitors of anthrax edema factor.

Authors:  Deliang Chen; Milind Misra; Laurie Sower; Johnny W Peterson; Glen E Kellogg; Catherine H Schein
Journal:  Bioorg Med Chem       Date:  2008-06-28       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.